« Chevrolet to Power Tony Stewart Racing in 2007 and Beyond | Main | U.S. POSTAL SERVICE: PRESIDENT BUSH SIGNS POSTAL LEGISLATION INTO LAW »

December 20, 2006

GlaxoSmithKline Completes Acquisition of CNS, Inc.

GSK adds innovative, high-growth Breathe Right and FiberChoice brands to Consumer Healthcare portfolio.

PHILADELPHIA, Dec. 19 -- GlaxoSmithKline (NYSE:GSK) today announced that it has completed the acquisition of CNS, Inc. (NASDAQ:CNXS) , the marketers of Breathe Right(R) nasal dilator strips and FiberChoice(R) dietary fiber supplements.

Commenting on the transaction, John Clarke, President, GSK Consumer Healthcare, said, "We are very pleased to welcome this outstanding business into the GSK Consumer Healthcare family. CNS is a well-managed company, and its brands fit with our growth strategy and are great additions to our portfolio. The opportunity for growth through geographic expansion and pipeline innovation makes this acquisition an exciting prospect."

Breathe Right strips are the leading nasal dilator strips worldwide, and FiberChoice is the fastest growing line of dietary fiber supplements in the United States. Both brands are supported by patents in the U.S. and key markets worldwide, and by scientific evidence for their product claims.

GlaxoSmithKline is one of the world's leading research-based pharmaceutical and healthcare companies.

Edited & Posted by the Editor | 6:50 PM | Link to this Post

---

---